Picture of CONTRAFECT logo

CFRXQ — CONTRAFECT News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

ContraFect Corp expected to post a loss of 22  cents a share - Earnings Preview

* ContraFect Corp  CFRX.OQ   CFRX.O  is expected to show a rise
in quarterly revenue when it reports results on May 17 .
* The Yonkers, New York-based company is expected to report
revenue of $2 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
​* Refinitiv's mean analyst estimate for ContraFect Corp is for
a loss of 22 cents per share. For the same quarter last year,
the company reported a loss of 49 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts had risen by about 2.9%
in the last three months. ​
* Wall Street's median 12-month price target for ContraFect Corp
is $14.5​, about 75.3% above​ its last closing price
of $3.58. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.22       -0.31      -0.23     Beat    24.8
 Sep. 30 2020  -0.27       -0.38      0.12      Beat    131.4
 Jun. 30 2020  -0.34       -0.37      -0.88     Missed  -139.1
                                                        ​
 Mar. 31 2020  -0.34       -0.62      -0.49     Beat    21
 Dec.          -0.64​      -0.83      -1.11     Missed  -33.7​
 31​ 2019​                                              
 Sep. 30 2019  -0.65       -0.77      -0.70     Beat    9.7​
 Jun. 30 2019  -0.75       -0.86      -1.10     Missed  -27.9
 Mar. 31 2019  -0.85       -1.02      1.50      Beat    246.3
 This summary was machine generated May 14 at 14:07 GMT.  All
figures in US dollars unless otherwise stated

Recent news on CONTRAFECT

See all news